Yang Xiuxiu, Gianetti Thomas L, Wörle Michael D, van Leest Nicolaas P, de Bruin Bas, Grützmacher Hansjörg
Department of Chemistry and Applied Biosciences , ETH Zürich , Vladimir-Prelog-Weg 1 , 8093 Zürich , Switzerland . Email:
Department of Chemistry and Biochemistry , The University of Arizona , Tucson , Arizona 85721 , USA . Email:
Chem Sci. 2018 Nov 15;10(4):1117-1125. doi: 10.1039/c8sc02864h. eCollection 2019 Jan 28.
The dinuclear ruthenium complex [RuH(μ-H)(Medad)(dbcot)] contains a 1,4-dimethyl-diazabuta-1,3-diene (Medad) as a non-innocent bridging ligand between the metal centers to give a [Ru(Medad)] core. In addition, each ruthenium is bound to one dibenzo[,]cyclooctatetraene (dbcot) ligand. This Ru dimer converts H to protons and electrons. It also catalyzes reversibly under mild conditions the selective hydrogenation of vitamins K and K to their corresponding hydroquinone equivalents without affecting the C[double bond, length as m-dash]C double bonds. Mechanistic studies suggest that the [Ru(Medad)] moiety, like hydrogenases, reacts with H and releases electrons and protons stepwise.
双核钌配合物[RuH(μ-H)(Medad)(dbcot)]包含一个1,4-二甲基-二氮杂丁二烯-1,3-二烯(Medad)作为金属中心之间的非无辜桥连配体,形成一个[Ru(Medad)]核。此外,每个钌与一个二苯并[,]环辛四烯(dbcot)配体结合。这种钌二聚体将H转化为质子和电子。它还在温和条件下可逆地催化维生素K和K选择性加氢生成相应的对苯二酚等价物,而不影响C[双键,长度为m破折号]C双键。机理研究表明,[Ru(Medad)]部分与氢化酶一样,与H反应并逐步释放电子和质子。